CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Joseph Parisi as US Director of Sales. In his new role, Joe will lead the expansion of the Company’s sales and support activities for the US market to address the growing demand for […]
Making clinical proteomics 100x more robust and 10x faster Odense – Evosep, a leading provider of sample preparation and separations solutions for mass spectrometry-based proteomics, proudly announces the appointment of Rick Carberry as the Vice President of the Americas. Rick Carberry has extensive commercial and marketing leadership experience in the Liquid Chromatography-Mass Spectrometry (LCMS) tools […]
Last year has been truly transformational for our company. Besides closing our seed financing round with Swisscom Ventures and the Moonshot Fund from Spectrum Value Management, we also accelerated on our commercial developments with leading semiconductor manufacturers. The team grew to 20 FTE to ensure sufficient bandwidth in getting our products through the qualification phases. […]
WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced that Sophie Vandebroek and Michael Klobuchar have been elected to its board of directors, effective February 1, 2024. “I am pleased to welcome Michael Klobuchar and Sophie Vandebroek to Revvity’s board and look forward to their contributions as we execute on our strategic vision,” said Alexis Michas, […]
Menlo Systems is pleased to announce the appointment of Jens Schumacher as the new General Manager of Menlo Systems Inc., its US subsidiary. Jens brings with him more than 20 years’ experience in the photonics industry, including long stretches at global photonics giants Coherent and Thorlabs. With previous roles covering sales, program and product line […]
EMERYVILLE, Calif. — Slingshot Biosciences Inc., a leader in the development of cell mimics for cell therapy, diagnostics, and rare disease research, is proud to announce the addition of Nicolas Barthelemy as its Executive Chair. “We have been working closely with Nicolas over the last two years and are excited to bring his experience, operational […]
In this role, Paul will lead the company’s global commercial strategy, drive business development initiatives, and play a pivotal role in fostering strategic partnerships. Paul Orange brings with him a wealth of experience in the bioprocessing industry, having held key leadership positions in various companies. His strategic vision, deep industry knowledge, and proven track record […]
Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore” or the “Group”), the company delivering a new generation of nanopore-based molecular sensing technology, today announces the expansion of the leadership team to support the business in its next phase of growth. Following a comprehensive search process, Nick Keher has been appointed as Chief Financial Officer (“CFO”) […]
Helge Bastian, PhD, joins executive team as new CEO. SAN DIEGO — iXCells Biotechnologies USA, Inc. (“iXCells”), a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, today announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive […]
* Senior biopharma and cell therapy engineering/operations executive with 30+ years of experience to help drive growth FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Steven Sandoval, Sr., to its Board of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
